N1C Appoints Hugh Hempel as Executive Director to Advance Rare Disease Treatments
The N=1 Collaborative (N1C), a non-profit organization representing over 700 researchers, physicians, and scientists dedicated to advancing treatments for rare disease patients, has appointed Hugh Hempel as its first Executive...
Read more